AnxietyVR-IUDNCT07580885
Virtual Reality-Assisted Nursing Intervention During Intrauterine Device Insertion
A study testing via virtual reality goggles in people with Anxiety and Pain Management, run by Mersin University at 1 site in Turkey (Türkiye).
Trial summary
Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial April 30, 2026 The aim of this study was to evaluate the effect of a virtual reality-assisted nursing intervention on participants' pain, anxiety, physiological parameters and… Read more about this study
- Who is it for?
- Ages 18 years and older, women onlyHealthy volunteers can take part
- Conditions the study is for
- Anxiety, Pain Management, Virtual Reality
- What is being tested?
- via virtual reality goggles
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 70 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 25 Feb 2024to 10 Apr 2026
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- Women only
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Being 18 years and older
- Being sexually active
- Having decided to have an IUD inserted
- Being gynecologically suitable for an IUD
- Having no communication impediment
Who cannot join
- Visual or hearing impairment
- Diagnosed psychiatric illness
- History of epilepsy
- Severe dizziness or condition that prevents VR use
- IUD contraindications detected during gynecological examination
Trial locations and contacts
1 site in 1 country.
Turkey (Türkiye)1 site
Women's and Children's Hospital
Gaziantep, 27270
About this study
Official title: Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial
Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial April 30, 2026 The aim of this study was to evaluate the effect of a virtual reality-assisted nursing intervention on participants' pain, anxiety, physiological parameters and comfort levels during Intrauterine Device (IUD) insertion. In this context, the study which hypothesises that the virtual reality application will reduce pain and anxiety during the procedure, support physiological stability, and enhance participants' comfort levels was designed as a randomised controlled trial.
Read the detailed description
The study's hypotheses:
Individuals receiving the virtual reality-supported nursing intervention (experimental group), compared to the control group (not individuals receiving the virtual reality);
- experience a lower level of pain during the procedure.
- experience lower levels of anxiety during the procedure.
- exhibit lower levels of stress response in physiological parameters (heart rate, blood pressure and respiratory rate).
- experience higher levels of comfort during the procedure. Condition or illness: Pain, anxiety, physiological parameters and comfort levels of individuals during IUD insertion Intervention: Virtual reality-assisted nursing intervention Stage: Women who have decided to have an IUD fitted Detailed Description Study Design Study Type: Interventional (Clinical Study) Actual Number of Participants: 70 participants Assignment: Random Intervention Model: Parallel Assignment Intervention Model Description: Prospective, parallel, two-arm, randomized controlled clinical trial, single-blind Blinding: Single (participant) Methods: The sample size was calculated using G*Power 3.1.9.4 software, based on a significance level of 5% (α = 0.05), a statistical power of 95%, and an effect size of 0.40, resulting in a minimum required sample of 64 participants (experimental = 32, control = 32).
Within the scope of the study, a total of 89 women were approached, and 12 declined to participate. Considering potential data loss, 77 participants were enrolled in the study. Following the pre-test, 7 participants who did not meet the inclusion criteria were excluded. No participants withdrew during the intrauterine device insertion procedure, and the study was completed with 70 participants (experimental = 35, control = 35).
Figure 1. CONSORT flow diagram
Randomisation and Groups In this study, given the nature of the intervention, it was anticipated that conducting the experimental and control groups on the same day could lead to information transfer between participants via communication (contamination) and behaviour changes related to the intervention (Hawthorne effect). Furthermore, administering the virtual reality application to some participants whilst not administering it to others within the same clinical setting could create a perception of unequal treatment among individuals, which could influence the study results.
Therefore, to minimise the risk of contamination and maintain the integrity of the clinical trial, participants were assigned to groups on a day-by-day basis. Participants who enrolled on specific days of the week were included in the experimental group, whilst those who enrolled on other days were included in the control group.
The similarity of baseline characteristics between the groups will be assessed statistically.
Intervention
Experimental Group (individuals receiving the virtual reality):
Participants in the experimental group were subjected to a virtual reality-assisted nursing intervention during the IUD insertion procedure. As part of this, participants were shown a 3D video lasting approximately 6 minutes, featuring nature-themed scenes (water, forest, sky) and accompanied by soothing music, via virtual reality goggles.
This intervention was designed as a non-pharmacological nursing intervention aimed at diverting the individual's attention away from the procedure and reducing pain and anxiety levels.
Control Group (not individuals receiving the virtual reality):
Participants in the control group will not receive any additional interventions beyond the routine care provided in the clinic during the IUD insertion procedure.
Data Collection Tools Data were collected in three phases: pre-procedure, during the procedure, and post-procedure.
Pre-procedure: A 7-item Information Form comprising demographic and descriptive characteristics; a 48-items the General Comfort Scale (GCS) and a 4-item Visual Analogue Scale (VAS) assessing anxiety, fear/apprehension, irritability and satisfaction regarding the IUD procedure, and by assessing blood pressure, pulse and respiratory rate.
During the procedure, pain levels immediately following the insertion of the speculum, tenaculum and IUD will be assessed using the VAS, and the pulse will be checked at each stage.
Five minutes after the procedure, blood pressure, pulse, and respiratory rate were assessed, and a 5-item VAS covering pain, tension, fear/anxiety, irritability, and satisfaction regarding the IUD insertion will be administered, along with the General Comfort Scale.
The study data were collected between February 2024 and December 2025. Ethical approval was obtained from the SANKO University Clinical Research Ethics Committee with decision number 2023-24. Informed consent was obtained from the participants.
General Comfort Scale: Developed by Kolcaba in 1992, and with Turkish validity and reliability studies conducted by Kuğuoğlu \& Karabacak in 2008, this is a four-point Likert-type scale consisting of three sub-dimensions (comfort, relaxation, superiority) and 48 items. The scale includes both positive and negative items, with negative items being reverse-coded. The total score obtained from the scale is divided by the number of items to find the average score. The minimum score on the scale is 48, and the maximum is 192. Based on the average scores obtained from the comfort scale, a score of 0-48 indicates a poor level, 49-96 indicates a moderate level, 50-144 indicates a good level, and 145-192 indicates a very good level. A higher score indicates a high level of comfort. The Cronbach's alpha value of the Turkish form of the scale is .85. In this study, both groups were evaluated together and the score was found to be 0.815 based on pre-test results.
Visual Analog Scale (VAS): Created by Albersnagel (1998), the VAS is a measurement tool in which each of 18 emotion expressions is placed on a separate plane. The scale consists of emotion adjectives where the person marks each emotion they are currently experiencing with a vertical line on a plane. Each emotion is rated between not experiencing the emotion at all (e.g., not at all tense = 0) and being fully experienced (e.g., extremely tense = 100). The VAS evaluates four emotion categories: Dysphoria, Hostility, Anxiety, and Positive Affect. Dysphoria includes adjectives such as depressed, sad, mournful, distressed, hopeless, and miserable. Hostility includes adjectives such as angry, rebellious, restless, and hostile. Anxiety includes adjectives such as anxious, uneasy, tense, and nervous. Positive Emotion consists of the adjectives happy, content, cheerful, and satisfied. Scoring is based on measuring the vertical markings made by the participant for each emotion on a plane using a ruler. Positive emotion adjectives are items that are reversed during scoring. In the Turkish validity and reliability study by Aydın et al. (2011), the scale was grouped under three factors: anxiety/unease, hostility, and positive emotion. The distribution of emotions according to these factors consists of the adjectives: Anxiety/Unease (depressed, sad, sorrowful, in distress, hopeless, miserable, worried, anxious, uneasy, tense, restless), hostility (angry, rebellious, irritable), and positive emotion (happy, content, cheerful, satisfied). According to the Turkish validity and reliability study, the Cronbach Alpha coefficients of the scale were found to be .93 for the Anxiety/Unease factor, .84 for the Positive Emotion factor, and .73 for the Hostility factor.
Materials to be Used in the Study:
- Virtual Reality Headset: Samsung GarVR2 SM-R321NZWATUR Virtual Reality Headset
- Video Prepared for the Virtual Reality Environment: As part of the study, the experimental group will be shown a virtual reality video titled 'Virtual Nature 360° - 5K Nature Meditation for Daydream, Oculus, Gear VR', which features nature scenes accompanied by calming music.
Data Collection Data will be collected by trained researchers using the face-to-face interview method. The data collection process will take an average of 15-20 minutes.
Participants will be informed about the research and an "Informed Consent Form" will be administered. The researcher will know who is in the experimental and control groups, but participants will not know which group they belong to. Participants will be blinded. Due to the nature of the research, the researcher cannot be blinded. When the research is complete, the data will be transferred to a computer environment by an independent researcher who does not know groups A and B, and the data will be analyzed by a statistician and the findings reported.
Statistical Analysis Data analysis will be conducted using the SPSS programme.
- Conditions
- Anxiety, Pain Management, Virtual Reality, Nursing Interventions
- Being tested
- via virtual reality goggles
- Keywords
- Virtual Reality, Pain, Anxiety, Nursing Intervention
- Medical subject headings
- Anxiety Disorders, Agnosia, Pain
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
via virtual reality gogglesOther
Intervention Name: Virtual Reality Intervention
Description:
Participants in the experimental group received a virtual reality-assisted nursing intervention during intrauterine device insertion. A virtual reality headset was used to present a 3D immersive video including relaxing natural scenes and calming background music. The intervention was applied continuously throughout the procedure to distract attention from the procedure and reduce pain and anxiety.
Intervention Name: Routine Care
Description:
Participants in the control group received routine care during intrauterine device insertion without the use of virtual reality or any additional distraction method.
| Study group | Role | What they receive |
|---|---|---|
| VR Group | Other | Intervention Name: Virtual Reality Intervention Intervention Type: Device (veya Behavioral) Assign to Arm: Experimental Group Receives: Other: via virtual reality goggles |
| Control Group | Other | Intervention Name: Routine Care Assign to: Control Group Receives: Other: via virtual reality goggles |
What is being measured
The primary outcome is the main question the study is designed to answer.
Pain Level
Pain intensity experienced during intrauterine device insertion, measured using a Visual Analog Scale.The score obtained from the scale ranges from 0 to 10. 0 means no pain, and 10 describes the most severe form of pain.
Measured: Immediately post-procedure (speculum, tenaculum, immediately after insertion, and post-procedure)
Secondary outcomes (2)
Anxiety Level
Anxiety levels assessed using a Visual Analog Scale during the procedure.The score obtained from the scale ranges from 0 to 10. 0 indicates no anxiety, while 10 describes the most severe level of anxiety.
Measured: Immediately post-procedure (speculum, tenaculum, immediately after insertion, and post-procedure)
Comfort Level
Patient comfort assessed using the General Comfort Scale before and after the procedure
Measured: 5 minutes before starting the IUD insertion procedure and 5 minutes after completing the IUD insertion procedure.
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted12 May 2026
- Study start25 Feb 2024
- Primary completion30 Dec 2025
- Study completion10 Apr 2026
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (3)Papers the sponsor has linked to this study.
- Other trials for AnxietyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Participant
- Enrolment
- 70 participants (actual)
Sponsor and investigators
- Lead sponsor
- Mersin University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, YASEMİN ATEŞEYAN, Mersin University
- Investigators
- Yasemin ATEŞEYAN, PhD, Principal investigator, MERSİN UNIVERSITYEsra VERİM, PhD, Study chair, GAZİANTEP UNIVERSITYEmine BAŞ, PhD, Study chair, Sanko UniversityZeynep GÜNGÖRMÜŞ, Prof, Study chair, Gaziantep Islam Science and Technology University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07580885
- Sponsor's protocol ID
- SANKO UNIVERSITY
- Other IDs
- YASEMİN ATEŞEYAN
- Acronym
- VR-IUD
- Status last verified
- Apr 2026
- First submitted
- 17 Apr 2026
- Last updated
- 12 May 2026
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Publications
Aydın, A., Araz, A., Asan, A. 2011. Görsel Analog Ölçeği ve Duygu Kafesi: Kültürümüze Uyarlama Çalışması, Türk Psikoloji Yazıları,14 (27), 1-13.
Kolcaba, K. (2003). Comfort Theory and Practice A vision for holistik health care and research, Springer Publishing Company. New York
Kuğuoğlu, S., & Karabacak, Ü. (2008). Genel Konfor Ölçeğinin Türkçe 'ye uyarlanması. İstanbul Üniversitesi Florence Nightingale Hemşirelik Yüksekokulu Dergisi, 61(16), 16-23.
Study at a glance
From the registry record, last updated by the sponsor on 12 May 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial
- ClinicalTrials.gov ID
- NCT07580885
- Acronym / sponsor ID
- VR-IUD / SANKO UNIVERSITY
- Conditions
- Anxiety, Pain Management, Virtual Reality, Nursing Interventions
- Keywords
- Virtual Reality, Pain, Anxiety, Nursing Intervention
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 70 participants (actual)
- Lead sponsor
- Mersin UniversityUniversity, hospital or other
- Study start
- 25 Feb 2024 (actual)
- Primary completion
- 30 Dec 2025 (actual)
- Study completion
- 10 Apr 2026 (actual)
- First posted
- 12 May 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
Effect of Virtual Reality-Assisted Nursing Intervention on Pain and Anxiety During Intrauterine Device Insertion: A Randomized Controlled Trial April 30, 2026 The aim of this study was to evaluate the effect of a virtual reality-assisted nursing intervention on participants' pain, anxiety, physiological parameters and comfort levels during Intrauterine Device (IUD) insertion. In this context, the study which hypothesises that the virtual reality application will reduce pain and anxiety during the procedure, support physiological stability, and enhance participants' comfort levels was designed as a randomised controlled trial.
Detailed description
The study's hypotheses:
Individuals receiving the virtual reality-supported nursing intervention (experimental group), compared to the control group (not individuals receiving the virtual reality);
- experience a lower level of pain during the procedure.
- experience lower levels of anxiety during the procedure.
- exhibit lower levels of stress response in physiological parameters (heart rate, blood pressure and respiratory rate).
- experience higher levels of comfort during the procedure. Condition or illness: Pain, anxiety, physiological parameters and comfort levels of individuals during IUD insertion Intervention: Virtual reality-assisted nursing intervention Stage: Women who have decided to have an IUD fitted Detailed Description Study Design Study Type: Interventional (Clinical Study) Actual Number of Participants: 70 participants Assignment: Random Intervention Model: Parallel Assignment Intervention Model Description: Prospective, parallel, two-arm, randomized controlled clinical trial, single-blind Blinding: Single (participant) Methods: The sample size was calculated using G*Power 3.1.9.4 software, based on a significance level of 5% (α = 0.05), a statistical power of 95%, and an effect size of 0.40, resulting in a minimum required sample of 64 participants (experimental = 32, control = 32).
Within the scope of the study, a total of 89 women were approached, and 12 declined to participate. Considering potential data loss, 77 participants were enrolled in the study. Following the pre-test, 7 participants who did not meet the inclusion criteria were excluded. No participants withdrew during the intrauterine device insertion procedure, and the study was completed with 70 participants (experimental = 35, control = 35).
Figure 1. CONSORT flow diagram
Randomisation and Groups In this study, given the nature of the intervention, it was anticipated that conducting the experimental and control groups on the same day could lead to information transfer between participants via communication (contamination) and behaviour changes related to the intervention (Hawthorne effect). Furthermore, administering the virtual reality application to some participants whilst not administering it to others within the same clinical setting could create a perception of unequal treatment among individuals, which could influence the study results.
Therefore, to minimise the risk of contamination and maintain the integrity of the clinical trial, participants were assigned to groups on a day-by-day basis. Participants who enrolled on specific days of the week were included in the experimental group, whilst those who enrolled on other days were included in the control group.
The similarity of baseline characteristics between the groups will be assessed statistically.
Intervention
Experimental Group (individuals receiving the virtual reality):
Participants in the experimental group were subjected to a virtual reality-assisted nursing intervention during the IUD insertion procedure. As part of this, participants were shown a 3D video lasting approximately 6 minutes, featuring nature-themed scenes (water, forest, sky) and accompanied by soothing music, via virtual reality goggles.
This intervention was designed as a non-pharmacological nursing intervention aimed at diverting the individual's attention away from the procedure and reducing pain and anxiety levels.
Control Group (not individuals receiving the virtual reality):
Participants in the control group will not receive any additional interventions beyond the routine care provided in the clinic during the IUD insertion procedure.
Data Collection Tools Data were collected in three phases: pre-procedure, during the procedure, and post-procedure.
Pre-procedure: A 7-item Information Form comprising demographic and descriptive characteristics; a 48-items the General Comfort Scale (GCS) and a 4-item Visual Analogue Scale (VAS) assessing anxiety, fear/apprehension, irritability and satisfaction regarding the IUD procedure, and by assessing blood pressure, pulse and respiratory rate.
During the procedure, pain levels immediately following the insertion of the speculum, tenaculum and IUD will be assessed using the VAS, and the pulse will be checked at each stage.
Five minutes after the procedure, blood pressure, pulse, and respiratory rate were assessed, and a 5-item VAS covering pain, tension, fear/anxiety, irritability, and satisfaction regarding the IUD insertion will be administered, along with the General Comfort Scale.
The study data were collected between February 2024 and December 2025. Ethical approval was obtained from the SANKO University Clinical Research Ethics Committee with decision number 2023-24. Informed consent was obtained from the participants.
General Comfort Scale: Developed by Kolcaba in 1992, and with Turkish validity and reliability studies conducted by Kuğuoğlu \& Karabacak in 2008, this is a four-point Likert-type scale consisting of three sub-dimensions (comfort, relaxation, superiority) and 48 items. The scale includes both positive and negative items, with negative items being reverse-coded. The total score obtained from the scale is divided by the number of items to find the average score. The minimum score on the scale is 48, and the maximum is 192. Based on the average scores obtained from the comfort scale, a score of 0-48 indicates a poor level, 49-96 indicates a moderate level, 50-144 indicates a good level, and 145-192 indicates a very good level. A higher score indicates a high level of comfort. The Cronbach's alpha value of the Turkish form of the scale is .85. In this study, both groups were evaluated together and the score was found to be 0.815 based on pre-test results.
Visual Analog Scale (VAS): Created by Albersnagel (1998), the VAS is a measurement tool in which each of 18 emotion expressions is placed on a separate plane. The scale consists of emotion adjectives where the person marks each emotion they are currently experiencing with a vertical line on a plane. Each emotion is rated between not experiencing the emotion at all (e.g., not at all tense = 0) and being fully experienced (e.g., extremely tense = 100). The VAS evaluates four emotion categories: Dysphoria, Hostility, Anxiety, and Positive Affect. Dysphoria includes adjectives such as depressed, sad, mournful, distressed, hopeless, and miserable. Hostility includes adjectives such as angry, rebellious, restless, and hostile. Anxiety includes adjectives such as anxious, uneasy, tense, and nervous. Positive Emotion consists of the adjectives happy, content, cheerful, and satisfied. Scoring is based on measuring the vertical markings made by the participant for each emotion on a plane using a ruler. Positive emotion adjectives are items that are reversed during scoring. In the Turkish validity and reliability study by Aydın et al. (2011), the scale was grouped under three factors: anxiety/unease, hostility, and positive emotion. The distribution of emotions according to these factors consists of the adjectives: Anxiety/Unease (depressed, sad, sorrowful, in distress, hopeless, miserable, worried, anxious, uneasy, tense, restless), hostility (angry, rebellious, irritable), and positive emotion (happy, content, cheerful, satisfied). According to the Turkish validity and reliability study, the Cronbach Alpha coefficients of the scale were found to be .93 for the Anxiety/Unease factor, .84 for the Positive Emotion factor, and .73 for the Hostility factor.
Materials to be Used in the Study:
- Virtual Reality Headset: Samsung GarVR2 SM-R321NZWATUR Virtual Reality Headset
- Video Prepared for the Virtual Reality Environment: As part of the study, the experimental group will be shown a virtual reality video titled 'Virtual Nature 360° - 5K Nature Meditation for Daydream, Oculus, Gear VR', which features nature scenes accompanied by calming music.
Data Collection Data will be collected by trained researchers using the face-to-face interview method. The data collection process will take an average of 15-20 minutes.
Participants will be informed about the research and an "Informed Consent Form" will be administered. The researcher will know who is in the experimental and control groups, but participants will not know which group they belong to. Participants will be blinded. Due to the nature of the research, the researcher cannot be blinded. When the research is complete, the data will be transferred to a computer environment by an independent researcher who does not know groups A and B, and the data will be analyzed by a statistician and the findings reported.
Statistical Analysis Data analysis will be conducted using the SPSS programme.
Study design
- Primary purpose
- Supportive care
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (participant)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| VR Group | Other | Other: via virtual reality gogglesIntervention Name: Virtual Reality Intervention Intervention Type: Device (veya Behavioral) Assign to Arm: Experimental Group |
| Control Group | Other | Other: via virtual reality gogglesIntervention Name: Routine Care Assign to: Control Group |
Who may qualify
- Ages
- 18 years and older
- Sex
- Female only
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (5 listed)
- Being 18 years and older
- Being sexually active
- Having decided to have an IUD inserted
- Being gynecologically suitable for an IUD
- Having no communication impediment
Key exclusion criteria (5 listed)
- Visual or hearing impairment
- Diagnosed psychiatric illness
- History of epilepsy
- Severe dizziness or condition that prevents VR use
- IUD contraindications detected during gynecological examination
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| via virtual reality gogglesIntervention Name: Virtual Reality Intervention Description: Participants in the experimental group received a virtual reality-assisted nursing intervention during intrauterine device insertion. A virtual reality headset was used to present a 3D immersive video including relaxing natural scenes and calming background music. The intervention was applied continuously throughout the procedure to distract attention from the procedure and reduce pain and anxiety. Intervention Name: Routine Care Description: Participants in the control group received routine care during intrauterine device insertion without the use of virtual reality or any additional distraction method. | Other | Control Group, VR Group |
Primary outcome
Pain Level
Time frame: Immediately post-procedure (speculum, tenaculum, immediately after insertion, and post-procedure)
Pain intensity experienced during intrauterine device insertion, measured using a Visual Analog Scale.The score obtained from the scale ranges from 0 to 10. 0 means no pain, and 10 describes the most severe form of pain.
2 secondary outcomes
Anxiety Level
Time frame: Immediately post-procedure (speculum, tenaculum, immediately after insertion, and post-procedure)
Comfort Level
Time frame: 5 minutes before starting the IUD insertion procedure and 5 minutes after completing the IUD insertion procedure.
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 12 May 2026.
- BackgroundAydın, A., Araz, A., Asan, A. 2011. Görsel Analog Ölçeği ve Duygu Kafesi: Kültürümüze Uyarlama Çalışması, Türk Psikoloji Yazıları,14 (27), 1-13.
- BackgroundKolcaba, K. (2003). Comfort Theory and Practice A vision for holistik health care and research, Springer Publishing Company. New York
- BackgroundKuğuoğlu, S., & Karabacak, Ü. (2008). Genel Konfor Ölçeğinin Türkçe 'ye uyarlanması. İstanbul Üniversitesi Florence Nightingale Hemşirelik Yüksekokulu Dergisi, 61(16), 16-23.
- Individual participant dataSharing planned: No
Related trials for Anxiety
Not yet recruiting
Building Resilience Through Anxiety Virtual Education in PICU Survivors
Critical Illness Recovery, Mental Health
Not yet recruiting
Mandala Coloring in Late Pregnancy
Pregnancy, Anxiety
Recruiting
Modulating Escape Using Focused Ultrasound
Anxiety Disorders
Not yet recruitingObservational study
Ecological Momentary Assessment of State-Dependent Decision-Making and Metacognition Across a Psychopathology Continuum
Depression, Anxiety
Recruiting
Stress and Anxiety Effects on Valuation
Reward Value Level
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Yasemin ATEŞEYAN, PhD principal investigator
MERSİN UNIVERSITY
Esra VERİM, PhD study chair
GAZİANTEP UNIVERSITY
Emine BAŞ, PhD study chair
Sanko University
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing via virtual reality goggles in people with Anxiety and Pain Management, run by Mersin University at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 12 May 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Pain Level (time frame: Immediately post-procedure (speculum, tenaculum, immediately after insertion, and post-procedure)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT07580885, which also lists 3 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 May 2026.